Difference between revisions of "ROS1-rearranged non-small cell lung carcinoma"

From Libre Pathology
Jump to navigation Jump to search
(create)
(No difference)

Revision as of 02:15, 31 December 2019

ROS1-rearranged non-small cell lung carcinoma is a subtype of non-small cell lung carcinoma that can be treated with inhibitors that significantly prolong survival.[1]

See also

References

  1. Shaw, AT.; Ou, SH.; Bang, YJ.; Camidge, DR.; Solomon, BJ.; Salgia, R.; Riely, GJ.; Varella-Garcia, M. et al. (Nov 2014). "Crizotinib in ROS1-rearranged non-small-cell lung cancer.". N Engl J Med 371 (21): 1963-71. doi:10.1056/NEJMoa1406766. PMID 25264305.